These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Change in N-terminal pro-B-type natriuretic peptide at 1 year predicts mortality in wild-type transthyretin amyloid cardiomyopathy. Law S; Petrie A; Chacko L; Cohen OC; Ravichandran S; Gilbertson JA; Rowczenio D; Wechalekar AD; Martinez-Naharro A; Lachmann HJ; Whelan CJ; Hutt DF; Hawkins PN; Fontana M; Gillmore JD Heart; 2022 Mar; 108(6):474-478. PubMed ID: 33990410 [TBL] [Abstract][Full Text] [Related]
7. The Association of Cardiac Biomarkers, the Intensity of Tc99 Pyrophosphate Uptake, and Survival in Patients Evaluated for Transthyretin Cardiac Amyloidosis in the Early Therapeutics Era. Martyn T; Saef J; Hussain M; Ives L; Kiang A; Estep JD; Collier P; Starling RC; Cremer PC; Tang WHW; Hanna M; Jaber WA J Card Fail; 2022 Oct; 28(10):1509-1518. PubMed ID: 35843490 [TBL] [Abstract][Full Text] [Related]
18. First Norwegian case of hereditary ATTR amyloidosis with a novel transthyretin variant. Lyng CS; Gude E; Hodt A; Knudsen EC Scand Cardiovasc J; 2023 Dec; 57(1):2174269. PubMed ID: 36734834 [TBL] [Abstract][Full Text] [Related]
19. Biomarkers and Prediction of Prognosis in Transthyretin-Related Cardiac Amyloidosis: Direct Comparison of Two Staging Systems. Cappelli F; Martone R; Gabriele M; Taborchi G; Morini S; Vignini E; Allinovi M; Di Gioia M; Bartolini S; Di Mario C; Perfetto F Can J Cardiol; 2020 Mar; 36(3):424-431. PubMed ID: 32145869 [TBL] [Abstract][Full Text] [Related]
20. Early Detection of Cardiac Amyloidosis in Transthyretin Mutation Carriers. Nagano N; Muranaka A; Nishikawa R; Ohwada W; Kouzu H; Kamiyama N; Fujito T; Mochizuki A; Nagahara D; Nakanishi M; Ohkubo Y; Hisahara S; Nakao S; Katoh N; Ishikawa A; Sakurai A; Yano T Int Heart J; 2022; 63(1):168-175. PubMed ID: 35095067 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]